LOS ANGELES–(BUSINESS WIRE)–Lundin Law PC (http://lundinlawpc.com/) announces it is investigating claims against Zosano Pharma Corporation (“Zosano” or the “Company”) (Nasdaq: ZSAN) concerning possible violations of federal securities laws.
To get more information about this investigation, please contact Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or via email at email@example.com.
No class has been certified in the above action. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.
The investigation concerns whether the Company violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. Specifically, the investigation will focus on whether the Company’s filings with the SEC concerning its January 2015 Initial Public Offering were misleading. The Company offered more than 6,500,000 shares of its common stock at $11.00 per share in connection with its IPO.
Lundin Law PC was founded by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.